Improving the Antitumor Effect of Chemotherapy with Ocoxin as a Novel Adjuvant Agent to Treat Prostate Cancer

Prostate cancer is one of the most common cancers among men. Although many patients respond favorably to first-line treatments, castration—and chemotherapy—resistance arises after a few years, leading to metastasis. Thus, new approaches are being investigated using natural supplements to reinforce c...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernandez-Unzueta, Iera, Benedicto, Aitor, Telleria, Uxue, Sanz, Eduardo, Márquez, Joana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10255289/
https://www.ncbi.nlm.nih.gov/pubmed/37299500
http://dx.doi.org/10.3390/nu15112536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10255289/
https://www.ncbi.nlm.nih.gov/pubmed/37299500
http://dx.doi.org/10.3390/nu15112536

Ejemplares similares